"If you're not using an intravascular imaging modality, the PCI is not optimal," explained Haroon Faraz, MD, from Hackensack University Medical Center. Faraz is hopeful new and improved technologies will help these modalities become more popular among interventional cardiologists.
“Physical AI agents being able to actually deliver some of these services—all the way into robotic surgery—this is where we're going to see this next chapter of medicine be written,” said Kimberly Powell, vice president and general manager of healthcare at Nvidia.
Cardiology has largely shifted to hospital-employed models, driven by reimbursement compression and evolving physician priorities. This has created challenges as well as opportunities.
ASE President David Wiener detailed some of the many ways imaging societies need to adapt now that so many imagers are specializing in multiple modalities. It may be time to change how annual conferences are scheduled, for example, so that the costs of travel are easier to manage.
As of January 2026, there will only be two CPT category 1 payment codes for newer AI, despite there being hundreds of FDA-cleared medical imaging algorithms.
Kathleen Campbell Walker, JD, immigration practice attorney, and past president of the American Immigration Lawyers Association (AILA), explains the barriers to global physician mobility amid growing shortages.
Pedro Martinez Clark, MD, FSCAI, interventional cardiologist, medical director of Amavita Heart and Vascular Health in Miami, set up community outreach efforts to screen patients in low-income neighborhoods.
American Hospital Association Director of Health Policy and Analytics Bharath Krishnamurthy explains how drug shortages and supply chain issues are negatively impacting U.S. healthcare.
Ron Blankstein, MD, director of cardiac computed tomography for Brigham and Women’s Hospital, details recent developments in cardiac MRI, nuclear imaging and CT.
Cardiologist Dan Blumenthal, MD, MBA, explains how changes in Medicare payments will greatly impact cardiology in the years ahead. In just a few short years, the business side of cardiology could look substantially different than it does today.
